pH-responsive folate-targeted catalase conjugate for enhanced cellular uptake and oxidative stress protection in triple-negative breast cancer
- 23 June 2026
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1030, 179081
Abstract
No abstract availableKeywords
Funding Information
- Khalifa University of Science, Technology and Research (RC2-2018-022)
This publication has 17 references indexed in Scilit:
- Tumor microenvironment-responsive precise delivery nanocarrier potentiating synchronous radionuclide therapy and chemotherapy against cancerJournal of Nanobiotechnology, 2025
- All-in-one approaches for triple-negative breast cancer therapy: metal-phenolic nanoplatform for MR imaging-guided combinational therapyJournal of Nanobiotechnology, 2022
- Folate Receptor-Alpha Targeted 7x19 CAR-γδT Suppressed Triple-Negative Breast Cancer Xenograft Model in MiceJournal of Oncology, 2022
- Fluorescein isothiocyanate-doped conjugated polymer nanoparticles for two-photon ratiometric fluorescent imaging of intracellular pH fluctuationsSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2022
- Optimization of Gold Nanoparticles for Efficient Delivery of Catalase to Macrophages for Alleviating InflammationACS Applied Nano Materials, 2020
- Human serum albumin: A nanomedicine platform targeting breast cancer cellsJournal of Drug Delivery Science and Technology, 2019
- Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systemsDrug Development Research, 2019
- Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid TumorACS Nano, 2019
- Optimization of anti-cancer drugs and a targeting molecule on multifunctional gold nanoparticlesNanotechnology, 2016
- Targeting receptor-mediated endocytotic pathways with nanoparticles: Rationale and advancesAdvanced Drug Delivery Reviews, 2013